InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 41313

Friday, 07/30/2021 7:30:57 AM

Friday, July 30, 2021 7:30:57 AM

Post# of 44690
This week, we are responding to an FDA information request for various, supplemental statistical analyses regarding the Phase 2b/3 data. In our experience, such requests are a routine part of the regulatory process and indicative of active engagement by the regulator.

https://www.nrxpharma.com/